TRIVENTURES MANAGEMENT LTD.

Thesis

Triventures is a venture capital firm founded in 2010 that focuses on investing in disruptive medical device and digital health companies, as well as those leveraging data-driven solutions and cross-industry convergence. The firm has a global reach with activities in Israel, the United States, and Canada. They target early-stage companies, specifically in Seed, Series A, and Series B rounds, looking for validated business models and innovative breakthroughs that impact healthcare quality and cost. Triventures emphasizes an operator-first mindset and a data-driven approach, often seeking companies with an affinity for the Israeli market, typically at post-seed stages with an approximate value of $5 million or more. The firm's geographic scope includes Israel, the United States, and Europe. As of September 2025, Triventures had made 81 investments. While specific fund sizes vary, Triventures Management Ltd. has AUM under $150 million, with Triventures overall managing approximately $200 million. Triventures IV, established in October 2019, is a fund dedicated to medical device and digital health technologies.

Related lists

• Seed-stage AI investors
• Seed-stage Healthcare investors
• Series A AI investors